Franz Groiss
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Influenza Virus Research Studies, Immune Response and Inflammation, Respiratory viral infections research
Most-Cited Works
- → A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication‐Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1(2009)130 cited
- → Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1(2013)53 cited
- → Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1(2019)24 cited
- → A randomized placebo-controlled phase II study with the cancer vaccine IGN101 in patients with epithelial solid organ tumors (IGN101/2–01)(2004)14 cited
- → A randomized placebo-controlled phase II study with the cancer vaccine candidate IGN101 in patients with epithelial cancers(2005)5 cited
- → A Randomized Placebo-Controlled Phase II Study with the Cancer Vaccine IGN101 in Patients with Epithelial Cancers(2004)3 cited
- → Randomized double-blind placebo-controlled phase II/III trial in adjuvant NSCLC patients with the candidate cancer vaccine IGN101(2008)2 cited
- Abstract #LB-157: Exploratory analysis of gender and age aspects in a finished placebo-controlled randomized trial with the cancer vaccine IGN101 in 762 NSCLC patients in the adjuvant setting(2009)
- → (185) SAFETY AND PRELIMINARY EFFICACY OF PHASE 1 TRIAL TARGETING HPV16 INFECTION AND CERVICAL LESIONS WITH INTERFERON-INDUCING VIRAL VECTOR DELNS/E6E7: A PLACEBO-CONTROLLED STUDY WITH 28 PATIENTS(2024)